Legacy Financial Advisors, Inc. Astrazeneca PLC Transaction History

Legacy Financial Advisors, Inc.

$498 Million
Q1 2025

A detailed history of Legacy Financial Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 11,736 shares of AZN stock, worth $866,468. This represents 0.17% of its overall portfolio holdings.

Number of Shares

11,736

Previous 7,073 65.93%

Holding current value

$866,468

Previous $463,000 86.18%

% of portfolio

0.17%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $304,820 - $363,527	4,663 Added 65.93%	11,736 $862,000
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $173,168 - $218,049	-2,740 Reduced 27.92%	7,073 $463,000
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $37,568 - $42,933	490 Added 5.26%	9,813 $764,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $40,152 - $48,578	601 Added 6.89%	9,323 $727,000
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $27,097 - $30,889	444 Added 5.36%	8,722 $590,000
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $10,954 - $12,262	-177 Reduced 2.09%	8,278 $557,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $39,817 - $44,023	614 Added 7.83%	8,455 $572,000
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $19,155 - $20,771	274 Added 3.62%	7,841 $561,000
Q1 2023 May 03, 2023	BUY	$63.15 - $71.6 $59,929 - $67,948	949 Added 14.34%	7,567 $525,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $53,776 - $69,876	992 Added 17.63%	6,618 $448,000
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $1,378 - $3,529	26 Added 0.46%	5,626 $309,000
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $31,467 - $37,775	531 Added 10.48%	5,600 $370,000
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $49,813 - $60,005	894 Added 21.41%	5,069 $336,000
Q4 2021 Feb 04, 2022	SELL	$54.02 - $63.83 $46,511 - $54,957	-861 Reduced 17.1%	4,175 $243,000
Q3 2021 Oct 26, 2021	BUY	$55.56 - $60.79 $68,894 - $75,379	1,240 Added 32.67%	5,036 $302,000
Q2 2021 Jul 21, 2021	BUY	$48.42 - $60.18 $183,802 - $228,443	3,796 New	3,796 $227,000
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $75,715 - $84,652	-2,031 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$36.86 - $41.49 $20,862 - $23,483	566 Added 38.63%	2,031 $77,000
Q2 2018 Jul 17, 2018	BUY	$34.55 - $37.05 $11,021 - $11,818	319 Added 27.84%	1,465 $54,000
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $36,775 - $39,857	1,146	1,146 $39,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $229B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account

Legacy Financial Advisors, Inc. Astrazeneca PLC Transaction History